NATCO Pharma Stocks Plummet Amid Profit Slump

Shares of NATCO Pharma Ltd fell by 20% following a report of a 37.75% decline in consolidated net profit for the December quarter. The company cites a significant drop in formulation exports as a key factor for decreased profits.

NATCO Pharma Ltd experienced a significant stock drop of 20% after announcing a sharp 37.75% decline in consolidated net profit for the December fiscal quarter.

The company’s share prices plummeted to Rs 973.40 on the BSE and Rs 975.05 on the NSE, hitting their lower circuit limits due to this financial disclosure.

The reported downturn is attributed to a slump in formulation exports, contributing to a valuation loss of Rs 4,356.85 crore and dropping revenues to Rs 474.8 crore from Rs 758.6 crore the previous year.